Headaches

Kristine Woods, Sarah Ostrowski‐Delahanty, Tami Cieplinski, Jonathan Winkelman, Pretti Polk, M. Cristina Victorio June 15, 2019

Background

Approximately 10% of pediatric patients have recurrent headaches, with migraine being the most common headache type. If untreated, migraine may progress to status migrainosus, a debilitating condition of prolonged duration, high pain severity, and significant disability. There is high variability in the treatment of status migrainosus including medications used and treatment setting, which may occur in the emergency room, as an inpatient admission, or, less often, in an outpatient infusion center.… Read More...

Allison L. Limmer, Levi C. Holland, Brian D. Loftus June 15, 2019

Objective

There is very little literature surrounding the prophylactic use of zonisamide in cluster headaches. The study aims to evaluate the effectiveness of zonisamide for prophylaxis of cluster headache in patients with chronic or episodic cluster headache.

Background

Both chronic and episodic cluster headaches are debilitating disorders which are often refractory to multiple prophylactic medication regimens.… Read More...

Stephen D. Silberstein, Peter McAllister, Xiaoping Ning, Nicola Faulhaber, Nicole Lang, Paul Yeung, Jimmy Schiemann, Ernesto Aycardi, Joshua M. Cohen, Lindsay Janka, Ronghua Yang June 15, 2019

Objective

Presentation of pooled analysis of safety data for fremanezumab in patients with chronic (CM) or episodic migraine (EM) from 4 placebo‐controlled phase 2b and phase 3 studies.

Background

There is a need for an effective, safe, and well‐tolerated preventive therapy that specifically targets the pathophysiology of migraine to reduce the frequency and severity of migraine attacks in patients with CM or EM who experience 4 or more migraine days per month.… Read More...

Bedia Samancı, Yavuz Samancı, Cömert Şen, Erdi Şahin, Mine Sezgin, Elif Kocasoy Orhan, Kadir Serkan Orhan, Betül Baykan June 15, 2019

Objective

Despite the lack of recognition in clinical practice, there is increasing evidence that patients with idiopathic intracranial hypertension may suffer from hyposmia. The current case‐control study aims to evaluate olfactory dysfunction in a large series of patients with idiopathic intracranial hypertension.… Read More...

Andoird App
Loading...